Details for: CL0000182

Cell ID: CL0000182

Cell Name: hepatocyte

Description: Hepatocytes are reportedly MHC Class I-positive and MHC Class II-positive.

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Image representation

Depiction of hepatocyte
Courtesy of SwissBioPics

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for hepatocyte within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for hepatocyte. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for hepatocyte. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for hepatocyte. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  hepatocyte (CL0000182)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [hepatocyte](/details-cell/CL0000182), the principal parenchymal cell of the liver, is a highly specialized epithelial cell central to metabolism, detoxification, and the synthesis of plasma proteins. The gene significance profile underscores its role as a metabolic powerhouse, defined by the highly specific expression of genes involved in mitochondrial respiration ([COX6A1](/details-gene/1337)), the urea cycle ([CPS1](/details-gene/1373)), and detoxification pathways ([GSTP1](/details-gene/2950)). Furthermore, its integral function in systemic innate immunity is highlighted by the prominent expression of complement components like [C9](/details-gene/735). This molecular signature paints a picture of a cell with an exceptionally high energy demand dedicated to maintaining systemic homeostasis and immune surveillance. ## Key Characteristics and Function The top marker genes for the [hepatocyte](/details-cell/CL0000182), based on expression specificity (`csi_z`), can be organized into several core functional clusters that define its biological role. * **Metabolic Engine:** The **Overall** context reveals a profound dedication to energy production and metabolic conversion. Top markers include multiple components of the mitochondrial electron transport chain, such as [COX6A1](/details-gene/1337), [COX1](/details-gene/4512), and [ND4](/details-gene/4538), supported by the ATP:ADP antiporter [SLC25A6](/details-gene/293). This is consistent with the immense ATP requirement for the diverse biosynthetic and detoxification functions of the liver. The high specificity of [CPS1](/details-gene/1373), the rate-limiting enzyme of the urea cycle ([Link](https://pubmed.ncbi.nlm.nih.gov/1840546/)), firmly establishes the [hepatocyte](/details-cell/CL0000182)'s unique and critical role in nitrogen waste disposal. * **Plasma Protein Synthesis and Secretion:** [Hepatocytes](/details-cell/CL0000182) are the primary source of many circulating proteins. This is evidenced by the high Cell Significance Index (CSI) for [C9](/details-gene/735) (terminal complement cascade component), [APOH](/details-gene/350) (beta-2-glycoprotein I), and [GC](/details-gene/2638) (vitamin D-binding protein). The expression of [B2M](/details-gene/567) is also consistent with the cell's description as being MHC Class I-positive, enabling it to present endogenous antigens. * **Detoxification and Stress Response:** The high ranking of [GSTP1](/details-gene/2950), a glutathione S-transferase, highlights the cell's central role in phase II detoxification, conjugating and neutralizing a wide range of xenobiotics and endogenous toxins. Genes involved in iron homeostasis, such as ferritin light and heavy chains ([FTL](/details-gene/2512) and [FTH1](/details-gene/2495)), further point to the liver's function in managing potentially toxic iron levels. * **Transcriptional and Post-Transcriptional Regulation:** A notable finding is the high specificity of the long non-coding RNA [NEAT1](/details-gene/283131), a core structural component of nuclear paraspeckles involved in gene regulation. This suggests that the unique transcriptional landscape of the [hepatocyte](/details-cell/CL0000182) is maintained by specialized nuclear architecture. Additionally, the high CSI for multiple RNA-binding proteins, including [PABPC1](/details-gene/26986), [HNRNPC](/details-gene/3183), and [HNRNPA2B1](/details-gene/3181), indicates robust post-transcriptional control, likely necessary to manage the vast and dynamic transcriptome of this cell. The anti-marker list does not point towards a specific lineage that [hepatocytes](/details-cell/CL0000182) actively suppress, but rather contains broadly expressed genes that lack the unique specificity required to be defining markers for this cell type. ## Clinical Significance and Contextual Roles As this analysis is limited to an **Overall** context without a comparative disease state, clinical significance must be inferred from the functions of the top marker genes, many of which are directly implicated in human disease. The most prominent example is [PNPLA3](/details-gene/80339), whose variants are strongly associated with the entire spectrum of non-alcoholic fatty liver disease (NAFLD), from simple steatosis to cirrhosis. Its high specificity in this dataset confirms its central role in [hepatocyte](/details-cell/CL0000182) lipid metabolism. Similarly, deficiencies in [CPS1](/details-gene/1373) are the cause of a severe inborn error of metabolism leading to life-threatening hyperammonemia ([Link](https://pubmed.ncbi.nlm.nih.gov/9711878/)). The role of the [hepatocyte](/details-cell/CL0000182) as a nexus of immunity and metabolism is also clinically relevant. The high specificity of [C9](/details-gene/735) underscores the liver as the primary producer of the terminal complement pathway, which is critical for defense against pathogens but can also contribute to inflammatory liver injury when dysregulated. The strong signal for [GSTP1](/details-gene/2950) is relevant in oncology and pharmacology, as its expression levels can influence cellular response to chemotherapy and oxidative stress-related liver damage. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The long non-coding RNA [NEAT1](/details-gene/283131) functions as a critical architectural hub for organizing the hepatocyte-specific transcriptome, potentially by sequestering transcription factors or RNA-binding proteins into paraspeckles to fine-tune the expression of metabolic and secreted protein genes. * **Surprising Findings:** The placement of a structural lncRNA among the most specific protein-coding genes like [COX6A1](/details-gene/1337) and [CPS1](/details-gene/1373) is unexpected. It suggests that the specialized nuclear organization conferred by [NEAT1](/details-gene/283131) may be as fundamental to [hepatocyte](/details-cell/CL0000182) identity as its enzymatic machinery. * **Testable Questions:** Does depletion of [NEAT1](/details-gene/283131) in a human [hepatocyte](/details-cell/CL0000182) model (e.g., HepG2 cells or primary cultures) lead to the mislocalization of RNA-binding proteins like [HNRNPC](/details-gene/3183) and a subsequent decrease in the transcription of key hepatocyte-specific genes like albumin, [GC](/details-gene/2638), and [CPS1](/details-gene/1373)? 2. **Hypothesis:** The synthesis of terminal complement components, marked by the high specificity of [C9](/details-gene/735), is directly coupled to the metabolic state and mitochondrial health of the [hepatocyte](/details-cell/CL0000182). This mechanism would allow the liver to modulate systemic innate immunity in response to metabolic stress or damage signals. * **Surprising Findings:** The expression specificity of an innate immune effector, [C9](/details-gene/735), rivals that of core metabolic genes. This suggests that producing complement is not merely a secondary liver function but a primary, defining characteristic that may be intrinsically linked to the cell's metabolic status. * **Testable Questions:** In primary [hepatocytes](/details-cell/CL0000182), does inducing mitochondrial stress via inhibitors of the electron transport chain (e.g., rotenone or antimycin A) cause a specific, dose-dependent reduction in the transcription and secretion of [C9](/details-gene/735), and is this effect more pronounced than the general effect on other secreted proteins?